Literature DB >> 8251938

Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.

J P Priestle1, J Rahuel, H Rink, M Tones, M G Grütter.   

Abstract

The three-dimensional structures of D-Phe-Pro-Arg-chloromethyl ketone-inhibited thrombin in complex with Tyr-63-sulfated hirudin (ternary complex) and of thrombin in complex with the bifunctional inhibitor D-Phe-Pro-Arg-Pro-(Gly)4-hirudin (CGP 50,856, binary complex) have been determined by X-ray crystallography in crystal forms different from those described by Skrzypczak-Jankun et al. (Skrzypczak-Jankun, E., Carperos, V.E., Ravichandran, K.G., & Tulinsky, A., 1991, J. Mol. Biol. 221, 1379-1393). In both complexes, the interactions of the C-terminal hirudin segments of the inhibitors binding to the fibrinogen-binding exosite of thrombin are clearly established, including residues 60-64, which are disordered in the earlier crystal form. The interactions of the sulfate group of Tyr-63 in the ternary complex structure explain why natural sulfated hirudin binds with a 10-fold lower K(i) than the desulfated recombinant material. In this new crystal form, the autolysis loop of thrombin (residues 146-150), which is disordered in the earlier crystal form, is ordered due to crystal contacts. Interactions between the C-terminal fragment of hirudin and thrombin are not influenced by crystal contacts in this new crystal form, in contrast to the earlier form. In the bifunctional inhibitor-thrombin complex, the peptide bond between Arg-Pro (P1-P1') seems to be cleaved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251938      PMCID: PMC2142260          DOI: 10.1002/pro.5560021009

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  30 in total

1.  Hirudin.

Authors:  D Bagdy; E Barabas; L Gráf; T E Petersen; S Magnusson
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.

Authors:  E Skrzypczak-Jankun; V E Carperos; K G Ravichandran; A Tulinsky; M Westbrook; J M Maraganore
Journal:  J Mol Biol       Date:  1991-10-20       Impact factor: 5.469

3.  Interaction of site specific hirudin variants with alpha-thrombin.

Authors:  J Dodt; S Köhler; A Baici
Journal:  FEBS Lett       Date:  1988-02-29       Impact factor: 4.124

4.  Kinetics of the inhibition of thrombin by hirudin.

Authors:  S R Stone; J Hofsteenge
Journal:  Biochemistry       Date:  1986-08-12       Impact factor: 3.162

5.  Use of site-directed mutagenesis to investigate the basis for the specificity of hirudin.

Authors:  P J Braun; S Dennis; J Hofsteenge; S R Stone
Journal:  Biochemistry       Date:  1988-08-23       Impact factor: 3.162

6.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

7.  Role of interactions involving C-terminal nonpolar residues of hirudin in the formation of the thrombin-hirudin complex.

Authors:  A Betz; J Hofsteenge; S R Stone
Journal:  Biochemistry       Date:  1991-10-15       Impact factor: 3.162

8.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

9.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

10.  The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin.

Authors:  M G Grütter; G Fendrich; R Huber; W Bode
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  15 in total

1.  Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin.

Authors:  Chang C Liu; Eric Brustad; Wenshe Liu; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2007-08-09       Impact factor: 15.419

2.  Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.

Authors:  G De Simone; A Lombardi; S Galdiero; F Nastri; R Della Morte; N Staiano; C Pedone; M Bolognesi; V Pavone
Journal:  Protein Sci       Date:  1998-02       Impact factor: 6.725

3.  Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.

Authors:  R Krishnan; A Tulinsky; G P Vlasuk; D Pearson; P Vallar; P Bergum; T K Brunck; W C Ripka
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

4.  Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.

Authors:  J L Richardson; B Kröger; W Hoeffken; J E Sadler; P Pereira; R Huber; W Bode; P Fuentes-Prior
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

5.  The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.

Authors:  J Vijayalakshmi; K P Padmanabhan; K G Mann; A Tulinsky
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

6.  Thrombin allosteric modulation revisited: a molecular dynamics study.

Authors:  Hermes Luís Neubauer de Amorim; Paulo Augusto Netz; Jorge Almeida Guimarães
Journal:  J Mol Model       Date:  2009-10-09       Impact factor: 1.810

7.  A novel Omp25-binding peptide screened by phage display can inhibit Brucella abortus 2308 infection in vitro and in vivo.

Authors:  Junbo Zhang; Fei Guo; Xiaoqiang Huang; Chuangfu Chen; Ruitian Liu; Hui Zhang; Yuanzhi Wang; Shuanghong Yin; Zhiqiang Li
Journal:  J Med Microbiol       Date:  2014-04-10       Impact factor: 2.472

8.  More than just one: multiplicity of Hirudins and Hirudin-like Factors in the Medicinal Leech, Hirudo medicinalis.

Authors:  Christian Müller; Katharina Mescke; Stephanie Liebig; Hala Mahfoud; Sarah Lemke; Jan-Peter Hildebrandt
Journal:  Mol Genet Genomics       Date:  2015-08-13       Impact factor: 3.291

Review 9.  Exosites in the substrate specificity of blood coagulation reactions.

Authors:  P E Bock; P Panizzi; I M A Verhamme
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

10.  Proton bridging in the interactions of thrombin with hirudin and its mimics.

Authors:  Ildiko M Kovach; Lazaros Kakalis; Frank Jordan; Daoning Zhang
Journal:  Biochemistry       Date:  2013-04-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.